Analytical Data
-
Gene name
EHF
- Application
-
Alternative Names
EHF；ESE3；ESE3B；ESEJ;ETS homologous factor
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NZC4
-
Expression Region
1-300aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMILEGGG VMNLNPGNNL LHQPPAWTDS YSTCNVSSGF FGGQWHEIHP QYWTKYQVWE WLQHLLDTNQ LDANCIPFQE FDINGEHLCS MSLQEFTRAA GTAGQLLYSN LQHLKWNGQC SSDLFQSTHN VIVKTEQTEP SIMNTWKDEN YLYDTNYGST VDLLDSKTFC RAQISMTTTS HLPVAESPDM KKEQDPPAKC HTKKHNPRGT HLWEFIRDIL LNPDKNPGLI KWEDRSEGVF RFLKSEAVAQ LWGKKKNNSS MTYEKLSRAM RYYYKREILE RVDGRRLVYK FGKNARGWRE NEN
-
Molecular Weight
37 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EHF (Epithelial Helix-Loop-Helix Factor) is a member of the ETS (E26 transformation-specific) transcription factor family, which plays a pivotal role in various biological processes, including cell differentiation, proliferation, and apoptosis. EHF is primarily expressed in epithelial tissues and is crucial for maintaining epithelial integrity and function. Research on EHF has garnered interest due to its involvement in various cancers, where altered expression levels can impact tumor progression and metastasis. The investigation of EHF as a recombinant protein has therapeutic implications, especially in cancer treatment, where modulating its activity could provide novel strategies for intervention. The ability to produce EHF as a recombinant protein allows for in-depth studies of its structural features, binding interactions, and functional assays to unravel its role in cancer biology. Additionally, recombinant EHF can be utilized in drug development, serving as a potential target for small molecule inhibitors or as a biomarker for disease prognosis. Understanding EHF's mechanisms may lead to new insights into epithelial cell behavior in both normal and pathological conditions, highlighting its significance in the field of molecular biology and clinical research.
